EDTA-plasma were incubated with [14C]methylamine and analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and fluorography. In addition to finding label in the a-chains of the secreted (C45) and predominant plasma (C4P) forms of C4, two additional molecules with apparent molecular weights of -168,000 (p168) and '125,000 (p125) covalently incorporated methylamine, indicating the presence of an internal thioester bond. These two molecules were present at a concentration of -5% of total plasma C4 and were not immunoprecipitated by antisera to C3 or a2-macroglobulin. A human hepatoma-derived cell line (HepG2), in addition to synthesizing C45 and small quantities of the polypeptide precursor of C4 (pro-C4), was found to secrete p168 and p125 at concentrations of 14±4.8 and 21±9.2% (mean±SD), respectively, of total secreted C4. These molecules were not found intracellularly. Both molecules were present on reduced, but not nonreduced, SDS-polyacrylamide gels. Chido (C4B) and Rodgers (C4A) alloantisera precipitated the C4A and C4B variants of pro-C4, p168, p125, and C4'. Both tryptic and Staphylococcus aureus V8 protease peptide analyses showed homology between p168 and the ,B-and a-chains and between p125 and the a-and -y-chains. Partial NIH2-terminal sequencing revealed that the ,-chain was NH2-terminal in p168 and that the a-chain was NH2-terminal in p125. Taken together, these data indicate that p168 and p125 represent unThis work was presented, in part, at
INTRODUCTION
The fourth component of complement (C4)1 is an -200,000-D glycoprotein consisting of three polypeptides, designated a, ,B, and 'y, linked together by disulfide bonds (1) . C4 is synthesized as pro-C4, a singlechain polypeptide, and is processed by intracellular cleavage to yield the secreted three-chain C4 molecule (2) (3) (4) . The order of the subunits in mouse and guinea pig pro-C4 has been determined to be #l-a--y (5-7). We have previously described and characterized human and mouse C4s, the secreted form of C4, which has an as-chain with an apparent molecular weight -5,000 greater than the aP-chain of C4V, the predominant 'Abbreviations used in this paper: a2M, a2-macroglobulin; ap, a-chain of C4P with M, of 93,000; as, a-chain of C4S with M, of 98,000; bis, N,N'-methylene bisacrylamide; C3 and C4, third and fourth components of complement; C4b, C4 activation fragment consisting of the ,#-and 'y-chains and the COOH-terminal portion of the a-chain; C4V, principal plasma form of C4; C4%, secreted form of C4; HepG2, hepatomaderived cell line; HPLC, high-performance liquid chromatography; MEM, minimum essential medium; PAGE, polyacrylamide gel electrophoresis; p125, 125,000-D polypeptide seen on reducing gels representing the uncleaved a-y-subunits of pro-C4; p168, 168,000-D polypeptide seen on reducing gels representing the uncleaved ,B-a-subunits of pro-C4. plasma form of C4 (8, 9) . C4S constitutes -8% of the total C4 found in human or mouse plasma and is converted extracellularly, presumably by proteolytic processing, to C4P. In our studies of the C4S molecule found in human plasma and that synthesized by a human hepatoma-derived cell line (HepG2), two additional C4-related molecules having M, of -~168,000 and -125,000 were detected on fluorographs of C4 immunoprecipitates analyzed under reducing conditions. In this report, we demonstrate that these two molecules represent incompletely processed two-subunit C4 fragments in which only one of the two intracellular cleavages of pro-C4 has occurred.
METHODS

Reagents
The IgG fraction of goat anti-human C4, anti-a2-macroglobulin (a2M), and anti-human C3 antisera were purchased from Atlantic Antibodies (Scarborough, ME). Radiochemicals used were [35S]methionine (1, 026 Ci/mmol), L- [4,5- IN) . Anti-Chido and anti-Rodgers alloantisera (10) were a generous gift from John Moulds (Gamma Biologicals, Houston, TX). All other chemicals were of reagent grade from standard sources.
Cells and biosynthetic labeling
HepG2, a human hepatoma-derived cell line, was obtained from the Wistar Institute of Anatomy and Biology (Philadelphia, PA) (4, 11) . Conditions for culturing and biosynthetic labeling with [35S]methionine, L- [4,5-3H] leucine, L-[3,4(n)-3H]valine, or L- [4,5-3H] lysine in methionine, leucine, valine, or lysine-free minimal essential medium (MEM), respectively, have been described (8 To obtain the intracellular fraction, cells radiolabeled for 2 h were washed with cold MEM supplemented with 10 mM EDTA and incubated in 10 mM EDTA-MEM for 10 min at 4°C. Cells were centrifuged at 1,000 g at 4°C and the cell pellet homogenized in 2 ml of 2 mM benzamidine, 2 mM phenylmethylsulfonyl fluoride, 2% Triton X-100, 5 mM EDTA, 20 mM Tris (pH 8.0) with a Dounce homogenizer. The intracellular fraction was then collected by centrifugation at 100,000 g for 1 h at 4°C and frozen at -70°C for later use.
Immunoprecipitation and immunoadsorption C3, C4, and a2M were immunoprecipitated from plasma at equivalence. Labeled C4 was immunoprecipitated from hepatocyte medium in the presence of carrier plasma, 1 mM phenylmethylsulfonyl fluoride, 0.5 M KCI, and 10 mM EDTA, washed, and prepared for electrophoresis and fluorography (6 (13) . Preparation of a linear gradient from 6 to 18% polyacrylamide with a 3% stacking gel, fixation, staining, destaining, and fluorography have been described (14) . Before drying, destained gels were treated with EN HANCE (New England Nuclear). For separation of the a-chains of C4 encoded by C4A (Rodgers) and C4B (Chido) genes, 10% polyacrylamide gels with an acrylamide/N,N'-methylene bisacrylamide (bis) ratio of 1:0.006 as described by Roos et al. (15) (22) . A blank cycle was used at the beginning of each cycle to remove nonspecific radioactivity. The thiazolinone derivatives were extracted with butyl chloride, dried, redissolved in 1 ml methanol, and added to 10 ml 3A70 scintillation fluid for counting radioactivity. Sperm whale apomyoglobin (100 nmol) was used as an internal standard. Sequencer repetitive yield was >99%.
RESULTS
p125 and p168 are antigenically related to C4 and possess the internal thioester bond. In our characterization of the C4' molecule (8) Three molecules, a2M and the a-chains of C3 and C4, are known to incorporate methylamine (18, 23, 24) . To evaluate the possibility that p168 and p125 phoresis (9% polyacrylamide gel) and fluorography. The fluorograph is shown. In this overexposed gel some nonspecific trapping of radioactivity is seen in a molecule with a Mr of -68,000, presumably human serum albumin. In contrast to p125 and the a-chains, radioactivity in this 68,000-D band was not in proportion to quantity of protein seen on the protein stain (not shown).
were related to a2M or C3, C4 was immunoprecipitated from serum, labeled with ['4C]methylamine, and their Mr compared. The Mr of a2M and the a-chain of C3 were -185,000 (25) and -110,000 (26) , respectively, and were distinct from p168 and p125 (data not shown). Immunoprecipitation of a2M, C3, and C4 from a human hepatoma cell line known to synthesize and secrete these three molecules (27) also revealed that p168 and p125 are not C3 or a2M (see below). That p125 and p168 (a) possess common antigenic determinants with C4, (b) incorporate methylamine, and (c) are not related to C3 or a2M suggests that they are C4-related peptides with an intact thioester bond in their a-chains. An incompletely processed precursor fragment of murine C4 has been described (20) . Thus, p168 and p125 are likely candidates for human C4 processing fragments. Furthermore, the Mr suggest that p168 and p125 are C4-related molecules with uncleavedf, + a-and a + -y-chains, respectively. The small quantities of material present in plasma, however, make definitive identification difficult. Hence, a human hepatoma cell line capable of synthesizing C4 was used to study these putative C4 molecules further.
Synthesis of p168 and p125 by HepG2. During our characterization of the C4S molecule (8), we noted that HepG2 synthesized and secreted, in addition to C4s, significant quantities of C4 molecules corresponding to p125 and p168 found in plasma (Figs. 3 a and 4) . Quantitation by densitometric scanning (mean of five experiments) indicated that p168 accounted for 14±4.8% (mean±SD) and p125 accounted for 21±9.2% of the secreted C4 molecules. These two molecules were not present on nonreduced gels (Fig. 3 b) , nor were they found intracellularly (Figs. 4 and 5). Furthermore, both p168 and p125 incorporate [3H]mannose (Fig. 5, lane 2) , indicating the presence of sugar moieties on both molecules. C4 is a glycoprotein with a complex carbohydrate moiety on the a-chain, high mannose units on the ,8-chain, and minimal or no carbohydrate on the -y-chain (29) . In these experiments, no incorporation of [3H]mannose was detected in the 'y-chain (Fig. 5) . Finally, the intracellular pro-C4 molecule migrated with a slightly faster mobility than the extracellular pro-C4 molecule (Figs. 4 and 5 ). This may reflect incomplete carbohydrate processing of the pro-C4 molecule.
Immunoprecipitation of a2M, C3, and C4 from labeled hepatocyte medium confirmed that p168 and p125 were not a2M or C3 (Fig. 6) (Fig. 7) . The two molecules were secreted concurrently and densitometric scanning at 2, 4, and 6 h postchase indicated that the ratios of C4s/pl68/pl25 were similar throughout the chase period. These data indicate that for up to 6 h after secretion, p168 and p125 are neither further processed in the hepatocyte cultures nor derived by extracellular proteolytic cleavage of pro-C4. Pulse-chase experiments with shorter (30 min or 1 h) pulse periods revealed similar data.
Tryptic peptide analysis and S. aureus V8 protease analyses. To elucidate further the structure of p125 and p168, the two molecules were analyzed by tryptic peptide analysis. p125, p168, and C4 a'-, ,B-, and ychains were purified by elution from SDS-polyacrylamide gels of C4 immunoprecipitates of labeled hepatocyte medium, digested with trypsin, and the tryptic peptides separated by HPLC. Fig. 8 , and 6 h in unlabeled methionine containing MEM. C4 was immunoprecipitated from 1-ml aliquots taken at each interval and analyzed on a 9% polyacrylamide gel. The as-chain sometimes migrates as a broad band and probably reflects a-chain heterogeneity.
combination of these two peptides in p168. The 5,000-D COOH-terminal fragment of as may account for further differences if p168 is a fl-aP-fragment, rather than a f3-as-fragment (see below and Fig. 12 ). This possibility is unlikely, however, since C4s is not converted to C4P in the hepatocyte cultures (Fig. 3) .
Peptide homology between p168 and the as-and Fig. 10 .
NH2-terminus of p168 and the a-chain is at the NH2-terminus of p125 (Fig. 10) . Together with the tryptic peptide and S. aureus V8 protease analyses, these data confirm that p168 and p125 represent incompletely processed #B-a-and a-y-fragments of pro-C4, respectively.
A comparison of the NH2-terminal sequences of p125 and p168 and those reported for a2M (31) and the a-and #-chains of C3 (32, 33) Pro-C4 (identified on the basis of molecular weight and immunoprecipitation by anti-C4 antisera), C4 aS-, and G4 ,B-chains were evaluated in a similar fashion. The NH2-terminal sequences of the as-and f3-chains secreted by the hepatocytes corresponded to previously reported sequences of C4 ap-and ,-chains (Fig. 10) . This is further proof that a' (p98) is an a-chain molecule with an additional peptide with an M, of -5,000 at the COOH-terminus (8 (34, 35) . By modifying the bis/ acrylamide ratio in SDS-polyacrylamide gels, the achain of C4 encoded by C4A (Rodgers) has a slightly slower relative mobility than the a-chain of C4 encoded by C4B (Chido) (15) . To evaluate the possibility that one peptide (,B-a or a-y) was derived from C4A (Rodgers) and the other peptide derived from C4B (Chido), labeled hepatocyte medium was immunoadsorbed with anti-Chido or anti-Rodgers alloantisera. These molecules were then compared with C4 purified by anti-C4 antisera with the modified bis/acrylamide ratio-polyacrylamide gels. Fig. 11 demonstrates that all four molecules (pro-C4, C4 #-a, C4 a-,y, and C4S) purified by anti-C4 antisera (lane 2) were also purified by both anti-Chido (lane 3) and anti-Rodgers (lane 4) alloantisera. Hence, both Chido and Rodgers variants exist for pro-C4, C4 3-a, C4 a-'y, and C4s secreted by the HepG2 cells. Finally, the fact that all four molecules could be purified by these alloantisera further substantiates that they are C4 molecules. Lys-Pro-Arg-Leu-Leu-Leu-Phe-X -ProLys-Pro-Gly-Leu-Leu-Leu-Lhe Phe Cys-
Comparison of partial amino-terminal amino acid sequences of C4a', C4,, p168, p125, and pro-C4 with known sequences of a-and a-chains of C4 (23, 24) , a2M (28) , and the a-and a-chains of C3 (29, 30 
DISCUSSION
In this report, we identify and structurally characterize two previously unrecognized human C4 molecules. These two molecules account for -5% of plasma C4, incorporate methylamine, and are not related to C3 or a2M. Furthermore, their M, on reduced gels are appropriate for two-chain C4 molecules with uncleaved (3-a-and a--y-subunits. Structural analysis by tryptic peptide and S. aureus V8 protease mapping of these molecules is consistent with the hypothesis that p168 contains both the (3-and a-chains and p125 contains both the a-and y-chains. Partial NH2-terminal sequencing demonstrates that in p168 the (3-chain is NH2-terminal and in p125 the a-chain is NH2-terminal. Because (3-a-and a-"y-fragments are not present on nonreduced gels, the remaining y-and (3-chains are presumably bound by disulfide bonds to their respective fragments.
Processing of pro-C4 to C4S requires at least two intracellular proteolytic cleavages. Failure of either one of these cleavages will yield incompletely processed pro-C4 molecules. That both (3-a-and a-y-fragments concurrently appear extracellularly suggests that (3-a cleavage is not a requirement for a--I cleavage, and vice versa. If intracellular processing of pro-C4 to C4s was an obligatory sequential event (e.g., (-a cleavage followed by a-y cleavage leading to secretion), one would expect to find at least one of the two incompletely processed fragments intracellularly. Goldberger and Colten (7) have demonstrated in vitro cleavage of single chain pro-C4 from guinea pig peritoneal macrophage lysates to the three-subunit C4 molecules by plasmin. A 130,000-D molecule, consistent in size with an uncleaved a--y-fragment, was also generated. The authors suggest that cleavage of the two intrachain sites of pro-C4 occurs in a sequential manner. In our experiments, the failure to detect either fragment intracellularly argues against such a hypothesis. Rather, both (3-a and a-y cleavages are likely to be independent of one another. These experiments, however, do not definitively address the normal sequence of the cleavages.
The lack of these fragments or C4s in the intracellular compartment further suggests that processing of pro-C4 to C4s is closely coupled to secretion. Roos et al. (36) have shown that glycosylation of mouse pro-C4 is important for its secretion. That (3-a-and a-yfragments are also glycosylated is consistent with this tight linkage between secretion and glycosylation. Furthermore, these data point out that the two intracellular proteolytic cleavages are not a prerequisite for glycosylation and that glycosylation precedes proteolytic cleavage.
Aside from glycosylation and (3-a and a-y proteolytic cleavages, intracellular processing of pro-C4 also includes the formation of a thioester bond. Since both (3-a-and a-y-fragments covalently incorporate methylamine, an intact thioester bond is present in both molecules. Thus, formation of the internal thioester is independent of the two intracellular cleavages.
Although the (3-a-and a-y-fragments make up -35% of C4 synthesized by HepG2, the two fragments account for only -5% of plasma C4. One explanation for this discrepancy is that these incompletely processed forms have a reduced half-life in vivo. An alternative explanation is that HepG2 may not be representative of normal liver cells and inefficiently processes pro-C4 molecules. Although this possibility cannot be totally excluded, the fact that in vitro cultures of normal mouse hepatocytes and mouse peritoneal macrophages also produce large quantities of partially processed precursor molecules (37, 38) is not supportive of the latter explanation. Moreover, the concentrations in plasma appear to be less than would be expected based on the synthesis in mouse hepatocyte cultures (P. Rosa, personal communication) . Hence the discrepancies between the amounts of 13-a-and a--y-fragments from hepatoma-derived cell cultures and plasma may be accounted for by a more rapid turnover rate in vivo. However, we cannot rule out the possibility that the two fragments are further processed in plasma to the individual chains linked by disulfide bonds.
Pro-C4 is also found extracellularly in hepatocyte culture at a concentration much higher (11.5±5.4%, mean±SD) than in plasma (1-3%) (39, 40) . Extracellular pro-C4 may result from inefficient intracellular cleavages, allowing pro-C4 to be secreted as a single polypeptide chain. Mouse and guinea pig pro-C4 have been shown to possess an NH2-to COOH-terminal sequence of 13-a--y (5, 7) . No sequence data, however, have been previously reported for human pro-C4. Our partial NH2-terminal sequence revealed that the 13-chain was NH2-terminal and provides further evidence that the sequence of human pro-C4, like guinea pig and mouse pro-C4, is also A3-a-7/.
Karp et al. (20) have recently observed a-'y-and presumed 13-a-fragments of C4 and sex-limited protein (Slp) among various intra-H-2 recombinant strains (37) . Both fragments were tightly linked to C4 and Slp genes (S-region). The cis-dominant expression of these two incompletely processed pro-C4 molecules in F1 mice suggested that the defect is in the structural C4 molecule, rather than in a S-region-linked protease. Based on these results, we favor the hypothesis that the human 1-a-and a-y-fragments described herein are not the result of deficiencies of intracellular proteases.
Variation in quantity among inbred strains of the a-y-and presumed 13-a-molecules was shown to be Sregion controlled in the mouse (20, 37) . There were also differences in the quantity of 13-a and a--among normal human donors. Most individuals had more p168 than p125 (Fig. 1) , although some had predominantly, if not entirely, p125 (Fig. 2) . As in the mouse, these differences may reflect structural variations among human C4 alleles. In this regard, correlations between the quantity of 13-a or a-y in human plasma and C4 phenotype as determined by agarose gel electrophoresis could be informative. C4 polymorphism has been described and postulated to be closely linked to the HLA-B locus (34, 35) . By a modified technique of immunofixation electrophoresis, this polymorphism has been shown to be controlled by two closely linked loci, C4A (fast) and C4B (slow) (34) . Awdeh and Alpers (41), using agarose gel electrophoresis, further separated six structural variants and a deletion allele at the C4A locus and two structural variants and a deletion allele at the C4B locus. Furthermore, Roos et al. (15) have visualized the Chido and Rodgers C4 a-chain variants by electrophoresis on SDS-polyacrylamide gels with a modified bis/acrylamide ratio (15) . We considered the hypothesis that if one of the two fragments (13-a or a-) was derived from one of the two C4 genes and the other fragment derived primarily from the other gene, different ,B-a-and a--y-cleavage sites may then give rise to inefficient cleavages in the respective molecules.
That C4V, C4s, C460+., C4,1+,a., and pro-C4 are immunoprecipitated by both anti-Rodgers and anti-Chido alloantisera rules out this hypothesis.
In summary, C4 appears to be composed of a family of structurally distinct molecules: C4V, C4s, C4#,a+, C4, ,,,-and pro-C4 are all found in plasma. Since all five molecules are found for both C4A and C4B genes by SDS-PAGE, at least 10 structurally distinct forms of C4 can be found in human plasma (Table I) . Although some of these molecules may be of limited physiologic importance, they provide important information concerning intracellular and extracellular processing (Fig.  12 ). After translation of C4 messenger RNA, C4 precursor is processed further by formation of the appropriate disulfide bonds (1), glycosylation of the as-chain with a complex sugar and the 13-chain with a high mannose sugar (29, 30) , and formation of the internal thioester bond (42) . Intracellular proteolytic cleavage of the 1-a and a-y bonds (Fig. 12, A) yields the secreted molecule C4'. Upon secretion, the presumed extracellu- 
